Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

W Liang, W Guan, R Chen, W Wang, J Li, K Xu… - The lancet …, 2020 - thelancet.com
China and the rest of the world are experiencing an outbreak of a novel betacoronavirus
known as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). 1 By Feb 12 …

Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis

J Cai, H Chen, M Lu, Y Zhang, B Lu, L You, T Zhang… - Cancer letters, 2021 - Elsevier
Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent
increase in pancreatic cancer incidence and mortality has resulted in an increased number …

[HTML][HTML] Worldwide burden of, risk factors for, and trends in pancreatic cancer

J Huang, V Lok, CH Ngai, L Zhang, J Yuan, XQ Lao… - Gastroenterology, 2021 - Elsevier
Background & Aims We evaluated global and regional burdens of, risk factors for, and
epidemiologic trends in pancreatic cancer among groups of different sexes and ages …

Updated epidemiology of gastrointestinal cancers in East Asia

J Huang, DE Lucero-Prisno III, L Zhang, W Xu… - Nature Reviews …, 2023 - nature.com
Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence
and one-third of cancer-related mortality. Although there has been much progress in …

Overall survival results from the POLO trial: a phase III study of active maintenance olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer

HL Kindler, P Hammel, M Reni… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE The phase III POLO study demonstrated significant progression-free survival
(PFS) benefit for active olaparib maintenance therapy versus placebo for patients with …

[HTML][HTML] Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study

N Nagata, S Nishijima, Y Kojima, Y Hisada, K Imbe… - Gastroenterology, 2022 - Elsevier
Background & Aims To identify gut and oral metagenomic signatures that accurately predict
pancreatic ductal carcinoma (PDAC) and to validate these signatures in independent …

[HTML][HTML] Injectable self-healing adhesive pH-responsive hydrogels accelerate gastric hemostasis and wound healing

J He, Z Zhang, Y Yang, F Ren, J Li, S Zhu, F Ma, R Wu… - Nano-micro letters, 2021 - Springer
Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are
well-established therapeutics for gastrointestinal neoplasias, but complications after …

[HTML][HTML] European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer

G Carioli, M Malvezzi, P Bertuccio, P Boffetta, F Levi… - Annals of …, 2021 - Elsevier
Background We predicted cancer mortality statistics for 2021 for the European Union (EU)
and its five most populous countries plus the UK. We also focused on pancreatic cancer and …

Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

T Conroy, P Pfeiffer, V Vilgrain, A Lamarca… - Annals of …, 2023 - annalsofoncology.org
The opportunity to detect pancreatic cancer (PC) when potentially curable depends on early
diagnosis and an ability to identify and screen high-risk populations before symptoms arise …

[HTML][HTML] Pancreatic cancer in 2021: What you need to know to win

V Tonini, M Zanni - World Journal of Gastroenterology, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer is one of the solid tumors with the worst prognosis. Five-year survival rate
is less than 10%. Surgical resection is the only potentially curative treatment, but the tumor is …